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ABSTRACT
Metazoan replication-dependent histone pre-
mRNAs undergo a unique 30-cleavage reaction
which does not result in mRNA polyadenylation.
Although the cleavage site is defined by histone-
specific factors (hairpin binding protein, a 100-kDa
zinc-finger protein and the U7 snRNP), a large
complex consisting of cleavage/polyadenylation
specificity factor, two subunits of cleavage stimula-
tion factor and symplekin acts as the effector of
RNA cleavage. Here, we report that yet another
protein involved in cleavage/polyadenylation, mam-
malian cleavage factor I 68-kDa subunit (CF Im68),
participates in histone RNA 30-end processing. CF
Im68 was found in a highly purified U7 snRNP prep-
aration. Its interaction with the U7 snRNP depends
on the N-terminus of the U7 snRNP protein Lsm11,
known to be important for histone RNA processing.
In vivo, both depletion and overexpression of CF
Im68 cause significant decreases in processing
efficiency. In vitro 30-end processing is slightly
stimulated by the addition of low amounts of CF
Im68, but inhibited by high amounts or by anti-CF
Im68 antibody. Finally, immunoprecipitation of
CF Im68 results in a strong enrichment of histone
pre-mRNAs. In contrast, the small CF Im subunit,
CF Im25, does not appear to be involved in histone
RNA processing.
INTRODUCTION
Pre-messenger RNAs undergo a series of processing reac-
tions, such as capping, splicing and 30-cleavage before they
are exported from the nucleus and serve as templates for
translation. During 30-end processing, the majority of
pre-mRNAs acquire a poly(A) tail in a concerted
cleavage/polyadenylation reaction (1). Several cis-acting
elements direct the required factors to the cleavage site.
In vertebrates, cleavage and polyadenylation speciﬁcity
factor (CPSF) recognizes the highly conserved AAUAA
A hexamer located 10–30-nt upstream of the cleavage site
(2), and cleavage stimulation factor (CStF) binds to a G/U
rich downstream sequence element (3). In addition,
symplekin, cleavage factors I and II, poly(A) polymerase
and nuclear poly(A) binding protein (PABN1) are
required during the reaction (1).
In contrast, the transcripts of replication-dependent
histone genes in metazoans lack introns and poly(A)
tails (4). Instead of the poly(A) tail, their mRNAs end in
a conserved 26-nt long sequence, 16nt of which form a
hairpin structure. The processing at the 30-end requires
only one endonucleolytic cut that usually occurs 5nt
after the hairpin. This cleavage reaction is mediated by
several trans-acting factors, among them the U7 small
nuclear ribonucleoprotein (snRNP) which binds by
RNA:RNA base pairing to a conserved histone down-
stream element (HDE) located a few nucleotides after
the processing site. The U7 snRNP exhibits a unique
ring-shaped protein complex composed of ﬁve Sm
proteins and two U7-speciﬁc Sm-like proteins, termed
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factors are the hairpin binding protein (HBP; also
termed stem-loop binding protein, SLBP) (7,8), a
100-kDa zinc-ﬁnger protein (ZFP100) (9) that connects
HBP bound to the upstream hairpin with the U7 snRNP
bound to the HDE, as well as an essential heat-labile
protein complex (10,11).
Thus, in the past, the two types of processing reactions
seemed to be very different, except, perhaps, for the chem-
istry of the ends produced and the preference for certain
nucleotides at the cleavage sites (12–14). However, in
2005, the endonuclease executing the cleavage after the
hairpin was identiﬁed as the 73kDa subunit of CPSF
(CPSF-73) (15) and the heat-labile factor (HLF) was
characterized as a complex composed of all ﬁve subunits
of CPSF, two subunits of CstF as well as symplekin (16).
In addition, the U2 snRNP was found to bind to an RNA
element in the coding region of replication-dependent
histone mRNAs and thereby to stimulate the U7-
snRNP-dependent 30-end formation (17), similarly to
interactions that occur between the last 30-splice site and
CPSF bound to the polyadenylation site during cleavage
and polyadenylation (18).
However, certain components of the cleavage/
polyadenylation machinery, including mammalian
cleavage factor I (CF Im), were not detected in the
heat-labile complex. CF Im is a heterodimer consisting
of a small 25-kDa subunit and one of three different
larger subunits of 59, 68 and 72kDa, respectively (19).
All three large polypeptides can be UV crosslinked to a
cleavage and polyadenylation substrate. In addition,
analysis of the kinetics of the cleavage reaction indicated
that interaction of CF Im with the RNA is one of the
earliest steps in the assembly of the cleavage/
polyadenylation complex. It facilitates the recruitment of
other processing factors and stabilizes the binding of
CPSF (20). The 68kDa subunit has a domain organiza-
tion that is reminiscent of spliceosomal SR proteins with
an N-terminal RNA recognition motif (RRM) and a
C-terminal RS-like domain (Figure 1). The RRM does
not bind strongly to RNA, but seems to function in the
interaction with the small subunit CF Im25 (21). The
RS-like domain of CF Im68 is sufﬁcient for the localiza-
tion in nuclear speckles (and in the nucleoplasm) and
mediates the interaction in vitro with a subset of shuttling
SR proteins (21,22).
Surprisingly, we have identiﬁed CF Im68 in our most
highly puriﬁed U7 snRNP preparations (5,6). We could
validate this association which appears to depend on the
N-terminus of Lsm11 in vitro and in vivo. In addition CF
Im68 co-precipitates histone mRNA precursors (as well as
some mature histone mRNA), and the efﬁciency of
histone RNA 30-processing seems to depend on the
presence of CF Im68 both in vivo and in vitro.
MATERIALS AND METHODS
Plasmids
Complementary DNA clones of mouse Lsm11 or its
MPL>AAA mutant in the pcDNA3-HA vector as
well as pGex-4T-derived plasmids containing the ﬁrst
156 amino-acid codons of Lsm11 or the MPL mutant or
the ﬁrst 202 amino acids of Nxf1 have been described
(6,23,24). pcDNA3-Flag-Lsm11 was constructed by
replacing the HA-tag of the pcDNA3-HA-Lsm11 vector
(6) with a linker encoding the Flag epitope. The cDNA for
CF Im68, kindly provided by Walter Keller (Biozentrum,
University of Basel), was subcloned into pcDNA3-HA
and pGex-4T1 (Amersham Biosciences). pMal-Tev-
HA-CF Im25 was constructed by inserting the CF Im25
open reading frame together with a linker encoding the
TEV protease cleavage site and the HA epitope into
pMal-c (New England Bioloabs). pCMV-Flag-CF Im25
has been described elsewhere (24).
To produce plasmids encoding HA-CF Im68-VC155,
HA-CF Im25-VC155, Flag-Lsm11-VN173 and Flag-
Lsm11/MPL-VN173, the open reading frames of CF
Im68, CF Im25, Lsm11 and Lsm11/MPL were ampliﬁed
by PCR from plasmids described above and subcloned in
the Venus vectors pHA-VC155 and pFlag-VN173 (25). In
this way, all the open reading frames are inserted between
an N-terminal tag (HA or Flag) and a C-terminal Venus
(VC or VN) fragment. The empty pHA-VC155 and
pFlag-VN173 were used as mock controls. As
colocalization controls in the absence of bimolecular
ﬂuorescence complementation (BiFC) signals, we used
the following plasmids lacking Venus fragments:
pcDNA3-HA-Lsm11, pcDNA3-HA-MPL, pCMV-
Flag-CF Im25. To test for an interaction with HA-CF
Im68-VC155, the CF Im25 open reading frame of
pGEM-CF Im25 was cleaved by EcoRI/XhoI and
inserted into pHA-VC155.
Sequences coding for short hairpin RNAs (shRNAs)
were inserted as double-stranded oligonucleotides into
pSUPERpuro between the BglII and HindIII sites as
described (26,27). Two different target sequences were
used for Lsm11 (50-GGTATTCACTCGACACATA-30
and 50-GTATTCACTCGACACATAA-30) and for Tcrb
(50-TAACCATGACTATATGTAC-30 and 50-GGCTGA
TCCATTACTCATA-30). In each construct, the sense
and antisense sequences are separated by a 9-nt spacer
(TTCAAGAGA) that allows the formation of a hairpin
loop. These vectors are referred to as pSUPuro-Lsm11-1
and -2 as well as pSUPuro-Tcrb-1 and -2. To obtain a
puromycin-selectable HA-CF Im68 expression plasmid
(HA-CFIm68-SUPuro), a fragment of pcDNA3-HA-
CFIm68 containing CMV promoter, HA-CF Im68 cDNA
and bovine growth hormone polyadenylation signal was
Figure 1. Domain organization of CF Im68. CF Im68 has a structure
reminiscent of spliceosomal SR proteins. It contains an N-terminal
RNA recognition motif (RRM) and a C-terminal charged domain.
Over its RRM, it interacts with the 25kDa subunit of CF Im. Its
C-terminal charged domain can bind to RNA and interacts with a
subset of spliceosomal SR proteins. The positions of the peptides
identiﬁed by microsequencing are indicated by thick bars.
7638 Nucleic Acids Research, 2010,Vol.38, No. 21inserted into pSUPERpuro (thereby replacing the shRNA
expression cassette). All clones were veriﬁed by DNA
sequencing. Details of the constructs are available on
request.
Antibodies
An antibody to GST-CF Im68 was raised in rabbits and
afﬁnity puriﬁed by binding to the recombinant protein
immobilized on nitrocellulose ﬁlters. On western blots,
this antibody was detected with anti-rabbit antibody
coupled to horse radish peroxydase (HRP; Promega). It
revealed a single  68-kDa protein in whole-cell extract
from human 293-T cells (data not shown). Other previous-
ly described antibodies were directed against Lsm10 and
Lsm11 (5,6), CF Im25 (19) and SmB/B0 (46). Flag-tagged
proteins were detected by anti-Flag M2 monoclonal
antibody (Sigma) coupled to HRP. HA-tagged proteins
were detected either directly with anti-HA antibody
(12CA5, Roche) coupled to HRP or indirectly with a
species-speciﬁc antibody coupled to HRP (Promega).
Hexahistidine-tagged proteins were detected by using an
anti-His antibody (HIS1, Sigma). Endogeneous b-actin
was detected with polyclonal anti-actin antibody (20–33,
Sigma).
For immunoﬂuorescence, we used anti HA-tag (6E2,
mouse monoclonal antibody, Cell Signaling) or anti Flag
M2 (mouse monoclonal antibody, SIGMA) as primary
antibodies and goat-anti-mouse Alexa ﬂuor 488 and 633
(Molecular Probes) as secondary antibodies.
U7 snRNP puriﬁcation and peptide sequencing
The puriﬁcation of U7 snRNPs and peptide micro-
sequencing (performed at the Harvard Microchemistry
Facility) have been described (5).
Cell culture and transfection
Human HeLa and 293-T cells were grown in Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen, AG, Basel,
Switzerland) supplemented with 10% fetal calf serum
(BioConcept, Allschwil, Switzerland), 100 U/ml penicillin
and 100mg/ml streptomycin (Invitrogen, AG, Basel,
Switzerland) at 37 C in a wet atmosphere containing
5% CO2. For plasmid transfection, they were grown to
60–70% conﬂuency in 10cm dishes and transfected with
10mg of the appropriate plasmids complexed with
Dreamfect (OZ Biosciences). Cells were usually harvested
48h post-transfection.
For the ﬂuorescence experiments of Figure 4 and
Supplementary Figure S3, HeLa cells were grown on
glass coverslips in Dulbecco’s modiﬁed Eagle’s Medium
High Glucose supplemented with 10% foetal bovine
serum, 2mM L-glutamine and 100U/ml penicillin/strepto-
mycin (all components from Euroclone) at 37 C, 5% CO2.
Plasmid transfections were performed after cells had
reached 80% conﬂuency by using Escort V transfection
reagent (Sigma) as recommended by the manufacturer.
Depletion and overexpression experiments
Hela cells were transfected with either two siRNAs against
CF Im68 (Ambion, IDs: s223186 and s21775) at 25nM
concentration each, with a single siRNA against CF
Im25 (Ambion, ID: s21770) or with a non-targeting
siRNA control (Ambion), each at 50nM concentration,
by using Lullaby reagent (OZ Biosciences) according to
the manufacturer’s instructions. The cells were split 1:1 at
24h post-transfection. After another 24h, a second round
of transfection with half the initial amount of siRNAs was
performed. Cells were harvested 4 days after the primary
transfection for RNA isolation and western blot analysis
of CF Im68.
For depletion of Lsm11, the cells were transfected in
six-well plates with a mixture of 0.5mg each of
pSUPuro-Lsm11-1 and -2 or, as control, a similar
mixture of pSUPuro-Tcrb-1 and -2. For the
overexpression of CF Im68, the cells were transfected
with HA-CFIm68-SUPuro in 10cm dishes by using
the standard Dreamfect protocol described above.
Control cells were either transfected with an empty
pSUPERpuro or with a pSUPERpuro derivate expressing
an HA-tagged EGFP. Both controls yielded similar
results, indicating that the strong expression from the
CMV promoter has no effect on its own. Culturing the
cells in the presence of 1.5mg/ml puromycin eliminated
untransfected cells. Three to 5 days after transfection,
cells were harvested for RNA isolation and western blot
analysis of CF Im68.
To assess the depletion of Lsm11, cDNA corresponding
to 100ng reverse transcribed RNA was subjected to a
Lsm11-speciﬁc PCR. The PCR was performed in a
volume of 25ml containing 12.5ml2   FastStart PCR
Mastermix (Roche) supplemented with a primer pair
speciﬁc for Lsm11 at a ﬁnal concentration of 200 nM
each, and 35 cycles were performed (for primer sequences
see Supplementary Table S1).
Interaction studies by co-immunoprecipitation
The preparation of whole cell or small-scale nuclear
extracts and immunoprecipitations were performed as
described (5). The extract from one 10cm dish (100ml)
was incubated with 100mg of RNase A (Sigma) for
20min at 30 C prior to immunoprecipitation. Proteins
were resolved on 12% high-TEMED SDS–polyacrylamide
gels (28), analysed by western blots with appropriate
antibodies (see below) and developed by the enhanced
chemiluminescence method (Amersham).
Interaction studies by GST pull-down assays
Tostudy protein–protein interactions in vitro, recombinant
GST (negative control) or GST fusion proteins were ex-
pressed in Escherichia coli BL21 Gold or BL21(DE3)LysS
transformed with pGex-4T-derived plasmids encoding
GST-fusions with the N-terminus of Lsm11, the
N-terminus of the Lsm11-MPL/AAA mutant or the ﬁrst
202 amino acids of Nxf1. MBP-CF Im25 and
MBP-TEV-HA-CF Im25 were expressed in BL21(DE3)
LysS and puriﬁed over an amylose resin (New England
Nucleic Acids Research, 2010,Vol.38, No. 21 7639Biolabs), followed by the removal of the MBP-tag from
MBP-TEV-HA-CF Im25 by digestion of the fusion
protein with ProTev protease (Promega). The puriﬁed
GST-fusions were coupled to glutathione sepharose 4B
beads (Amersham Biosciences) and incubated with baculo-
virus produced hexahistidine-tagged CF Im68 or bacterial-
ly produced HA-tagged CF Im25. The beads and proteins
were incubated in IIP150-NP40 (10mM Tris–HCl, pH 8.0,
150mM NaCl, 0.1% Nonidet P-40) at 4 C for 2h with
gentle agitation on a wheel. Subsequently, the beads were
washed with IIP150-NP40 and the bound and input ma-
terials were resolved on 12% high-TEMED SDS–poly-
acrylamide gels (28), analysed by western blots with
appropriate antibodies (see above) and developed by the
enhanced chemiluminescence method (Amersham).
Li-Cor western blots
Western blots were performed essentially as described
above. Bands were visualized with secondary antibody
donkey anti rabbit IRDye800CW (Figure 5F). Bands
were quantiﬁed with an Odyssey Infrared Imaging
system (LI-COR Biosciences).
BiFc detection
HeLa cells that had been incubated for 24h after trans-
fection were washed with PBS (130mM NaCl, 20mM po-
tassium phosphate, pH 7.4), ﬁxed for 10min with PBS
containing 4% (w/v) paraformaldehyde and mounted in
Fluorsave Reagent (Calbiochem).
For measurement of Venus Fluorescent Protein ﬂuores-
cence after complementation, the YFP beam-path was
used as described (29). Complementation of the
C-terminal YFP fragment VC155 with the N-terminal
YFP fragment VN173 generates a ﬂuorophore with an
excitation maximum at 515nm and an emission
maximum at 528nm. Therefore, the ﬂuorescence resulting
from complementation was recorded through the Leica
laser scanning acquisition system by using the argon
laser line of excitation.
For immunoﬂuorescence, cells ﬁxed as described above
were washed with PBS, permeabilized in CKS solution
(HEPES 20mM, sucrose 300mM, NaCl 50mM, MgCl2
3mM, Triton-X-100 0.2%) for 5min at 4 C, blocked in
PBS containing 10% foetal bovine serum for 1h at room
temperature, and incubated with the primary antibodies
diluted in PBS containing 0.2% bovine serum albumin
(BSA) for 1h at 37 C. Subsequently, cells were washed
with PBS (three times for 5min) and incubated with the
secondary antibody diluted in PBS/0.2% BSA for 45min
at room temperature. The cells were again washed with
PBS (three times for 5min) and mounted in Fluorsave
Reagent (Calbiochem).
Images were collected with a confocal microscope Leica
TCS SP2 AOBS, by using LSC software. Fluorophores
were excited by using standard laser lines.
Quantitative reverse transcription PCR
Usually 400–1000ng RNA were reverse transcribed in
50ml Stratascript 6.0 RT buffer in the presence of 4mM
of all four desoxy nucleoside triphosphates, 300ng
random hexamers, 40U RNasIn (Promega) and 1ml
Stratascript 6.0 reverse transcriptase (Stratagene). For
real-time PCR, reverse-transcribed material correspond-
ing to 40ng RNA was ampliﬁed in 25ml Universal PCR
Master Mix, No AmpErase UNG (Applied Biosystems)
with speciﬁc primers, and TaqMan probes by using the
ABI SDS7000 Sequence Detection System. The TaqMan
assays for endogenous histone H3 RNA are speciﬁc for
the histone H3A/C genes (Homo sapiens histone cluster 2,
H3A and H3C; the sequences of the two transcripts are
identical and will henceforth be referred to as H3C).
The assays use probes spanning the start codon and the
30-cleavage site to measure total RNA and pre-mRNA,
respectively (Supplementary Table S1).
Northern blot
Samples of 10mg nuclear RNA, isolated as described (24),
were separated on a 3.6% polyacrylamide gel containing
7M urea in 1  TBE and transferred onto positively
charged Nylon membranes (Roche Applied Sciences) in
0.5  TBE at 400 mA by using a TE 77 ECL Semi-dry
transfer unit (GE Healthcare). RNA was cross-linked to
the membrane in a UV Stratalinker 2400 (Stratagene) by
application of 120mJ ultraviolet light (254nm).
Hybridization was carried out in ULTRAhyb
Ultrasensitive Hybridization Buffer (Applied Biosystems)
at 68 C. The histone H3C 50 and 30-probes were generated
by run-off transcription incorporating a-[
32P]-UTP
(Hartmann Analytic GmbH). They hybridize to nt 1–130
and 448–507, respectively, of Histone H3C (NM_021059).
After detection of the histone mRNA signals, the blot
was rehybdrized with a [
32P]-labelled oligonucleotide
complementary to 18S rRNA (50-CTTTCGCTCTGGTC
CGTCTTGCGCCGGTCC-30) in ULTRAhyb-Oligo
Hybridization buffer (Applied Biosystems) at 42 C.
Excess of probe or oligo were removed by following the
instructions of the ULTRAhyb protocol. Signals were
detected with a Phosphoimager Storm 820 (810-UNV)
scanner.
In vitro histone RNA 30-end processing
Processing reactions were carried out with 24ml of HeLa
nuclear extract and 10000 cpm (1–3fmol) 12/12 RNA
template (30) in a total volume of 40ml and incubated
for 90min at 30 C, unless stated otherwise. To the pro-
cessing reactions different amounts of either BSA or
hexahistidine-tagged CF Im68 in Buffer D (20mM
HEPES [pH 7.9], 20% glycerol, 100mM KCl, 0.2mM
EDTA and 0.5mM DTT) were added. After incubation
at 30 C, 1ml TRI reagent was added followed by subse-
quent puriﬁcation of the RNA. In some experiments,
 1.2mg rabbit polyclonal anti-HA (Y-11 probe, Santa
Cruz), rabbit polyclonal anti-b-actin (20–33, Sigma
Aldrich), rabbit polyclonal anti-CDC73 (A300-170A,
Bethyl) or rabbit polyclonal anti-CFIm68 were added to
the processing reaction mix without substrate and
incubated for 10min on ice. After addition of the process-
ing substrate, the reaction was incubated for 1h 45min at
30 C. The samples were resolved by 8% denaturing poly-
acrylamide gel electrophoresis (7M urea). The gel was
7640 Nucleic Acids Research, 2010,Vol.38, No. 21dried and revealed on a Storm820 Phosphoimager
(Amersham). The band intensities were quantitated by
using Aida software V3.11 (Raytest Isotopenmessgera ¨ te
GmbH, Straubenhardt).
RNA Immunoprecipitation
RNA immunoprecipitation was performed essentially as
described (31). Brieﬂy, 2.5   10
7cells were ﬁxed in 1%
formaldehyde for 30min at room temperature, lysed in
FA lysis buffer (50mM HEPES-KOH [pH 7.5], 150mM
NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium
deoxycholate, protease inhibitors) containing RNase in-
hibitor [RNAsin (Promega); 80U/500ml buffer], and then
nucleic acids were fragmented by sonication. Before
immunoprecipitation, the extract was treated with DNase
[400–500 units RNase-free DNase I (Sigma) per 500ml
extract] in 25mM MgCl2, 5mM CaCl2,3 ml RNAsin for
10min at 37 C. DNase I digestion was stopped by the
addition of EDTA to 20mM. Reactions were cleared by
centrifugation at 16100g in a microcentrifuge for 15min.
For input RNA, all following steps up to proteinase K
digestion were omitted. Immunoprecipitation was per-
formed by adding 30mg anti-CF Im68, 30mg BSA
(negative control), 50mg anti-CF Im25 or 50mg anti-b-
actin (negative control) to the DNase-treated extract and
incubating head over tail at 4 C overnight. Then 67mlo f
protein G slurry (equilibrated in FA lysis buffer containing
RNasin) were added to each tube and incubated for 2h at
4 C. All subsequent precipitate washes and the ﬁnal
elution were performed as described in (31). To the
eluate fractions, NaCl was added to a ﬁnal concentration
of 200mM before addition of 80mg proteinase K and in-
cubation at 42 C for 1h. Crosslinks were reversed by
heating at 65 C for 5h. The reactions were extracted
with an equal volume of acid-equilibrated (pH 4.8) phe-
nol:chloroform 5:1. Then, 1/10 volume of 3M sodium
acetate (pH 5.5), 20mg glycogen, and 2.5 volumes of
ice-cold absolute ethanol were added to the aqueous
layer before precipitation at  80 C. The reaction was
centrifuged at maximum speed in a microcentrifuge for
15min and the precipitate washed twice with ice-cold
70% ethanol. To remove contaminating DNA, RNA was
treated with Turbo DNase (Ambion) according to the
manufacturer’s protocol.
RESULTS
Identiﬁcation of CF Im68 as an interaction partner of
the U7 snRNP
We previously reported the puriﬁcation of U7 snRNPs
and the characterization of some of the associated
proteins including the U7-speciﬁc protein Lsm10 (5).
Apart from the subunits already described, two additional
bands of  70 and  50kDa, respectively, were present in
our most highly puriﬁed U7 snRNP preparation [marked
with asterisks in Figure 1C of (5)]. Microsequencing of the
50kDa band later led to the identiﬁcation of Lsm11 (6).
The band of  70kDa was also subjected to
microsequencing by nano-electrospray tandem mass spec-
trometry coupled to the Sequest database search
algorithm (32). This analysis revealed several peptides
from bovine serum albumin (theoretical, unmodiﬁed mo-
lecular mass: 69293 Da) and human cytokeratin 10
(59511 Da) that we considered to be contaminants.
Additionally, the peptides GFALVGVGSEASSK,
AISSSAISR and GPPPTDPYGRPPPYDR were indica-
tive of the 68kDa subunit of cleavage factor I (CF Im68;
59210 Da). The location of the peptides is indicated in
Figure 1 as bars below the schematic domain organization
of CF Im68.
Because it was not clear whether this association with
highly puriﬁed U7 snRNPs might be due to a contamin-
ation or reﬂect a real interaction, we immunopreciptated
U7 snRNPs from total cell extract of 293-T cells express-
ing HA-tagged CF Im68. Separate precipitations were
carried out with antibodies speciﬁc for Lsm10 (5) or
Lsm11 (6), and co-precipitation of CF Im68 was
analysed by western blotting with anti-HA antibody.
Indeed, HA-CF Im68 was efﬁciently co-precipitated by
both antibodies, but not by beads alone (Figure 2A).
Since the extracts had been treated with RNAse A, the
interaction of CF Im68 with the U7 snRNP-speciﬁc
proteins Lsm10 and Lsm11 was apparently not mediated
by RNA but rather due to a protein–protein interaction.
In an inverse experiment, protein G sepharose beads
coupled with anti-b-actin (negative control) or anti-CF
Im68 were used. However, in this case, nuclear extract
from HeLa cells expressing Flag-tagged Lsm11 was
used. The western blot was probed with anti-Flag
antibody, and the results indeed showed that the
Figure 2. CF Im68 interacts with Lsm10 and Lsm11. (A) HA-tagged
CF Im68 was expressed in human 293-T cells and its ability to interact
with Lsm11 and Lsm10 was assessed by immunoprecipitation of whole
cell extracts with antibodies speciﬁc for Lsm11 (lane 3) and Lsm10
(lane 4). Negative control (lane 2), beads incubated with bovine
serum albumin. Input, 1/30 of the amount used in the
co-immunoprecipitation. (B) Flag-tagged Lsm11 was expressed in
HeLa cells and its ability to interact with CF Im68 was assessed by
immunoprecipitation of small scale nuclear extracts with an antibody
speciﬁc for CF Im68. An antibody speciﬁc for b-actin served as negative
control (lane 3). In both cases, the extracts had been treated with
RNAse A. Lanes 1 and 2 are 1/10 and 1/15 of the amount used in
the co-immunoprecipitation, respectively.
Nucleic Acids Research, 2010,Vol.38, No. 21 7641anti-CF Im68 antibody can co-precipitate Flag-Lsm11
(Figure 2B). Note that we could not probe for a
co-precipitation of endogenous Lsm11, because its abun-
dance is below the detection limit of western blots (data
not shown).
As CF Im68 is usually found in a complex with CF Im25
(19), we tested whether the small 25kDa subunit of CF Im
is also associated with Lsm11. However, we could not
detect any interaction, by trying to precipitate either
Flag-tagged Lsm11 with anti-CF Im25 antibody or CF
Im25 with anti-Flag antibody from cells expressing
Flag-Lsm11 (Supplementary Figure S1).
CF Im68 interacts directly with the N-terminus of Lsm11
The N-terminus of the U7-speciﬁc Lsm11 protein and,
more speciﬁcally, an evolutionarily conserved amino acid
motif, NVLTRMPLH, are essential for histone RNA
30-end processing but not required for incorporation of
Lsm11 into U7 snRNPs (6,23,33). To investigate if CF
Im68 directly interacts with this part of Lsm11, we
coupled puriﬁed, recombinant, GST-tagged N-terminal
fragment of Lsm11 to glutathione beads and used these
to precipitate hexahistidine-tagged CF Im68 puriﬁed from
a baculovirus expression system. Indeed, CF Im68 inter-
acted with the wild-type N-terminus of Lsm11, but not
with a mutant in which the three amino acids MPL of
the mentioned motif had been replaced by alanines (23)
(Figure 3A, lanes 3 and 4). Additionally, no binding was
observed to beads loaded with a GST fusion of the ﬁrst 202
amino acids of the nuclear export factor Nxf1 (Figure 3A,
lane 2) (24). These interaction data were conﬁrmed by
GST-pulldowns using in vitro translated HA-tagged CF
Im68, and we also found that the GST-fusion of the
N-terminus of Lsm11 could bind CF Im68 from an
extract of mammalian cells (data not shown).
CF Im68 is normally in a complex with CF Im25, but the
small subunit was neither found in the U7 snRNP puriﬁ-
cation, nor in Lsm11 co-precipitations. However, we
wondered whether at least in vitro assembled CF Im and
the N-terminus of Lsm11 can form a trimeric complex or
whether CF Im25 competes with Lsm11 for the binding to
CF Im68. To adress this question we repeated the GST
pulldown experiments, but this time adding recombinant
HA-tagged CF Im25 to the binding reaction between the
GST-tagged Lsm11N-terminal fragment and CF Im68. As
can be seen in Figure 3B, CF Im25 does not interact
directly with Lsm11 (lane 4) but can form a trimeric
complex in vitro by interaction with CF Im68 (lanes 6–8).
When higher molar ratios of CF Im25 in respect to CF
Im68 are added to the binding reaction, the amount of
precipitated CF Im25 does not increase, showing that the
co-precipitated amount of CF Im25 depends on the
precipitated amount of CF Im68. This experiment was
also performed with MBP-CF Im25 yielding the same
results (data not shown).
In vivo interaction of CF Im68 with Lsm11 but not the
MPL mutant
To analyse whether the interaction between CF Im68 and
the U7 snRNP or Lsm11 can be detected in unperturbed
cells in vivo, we used the recently developed method of
BiFC (25,34). In this method, ﬂuorescent proteins are
split into two non-ﬂuorescent halves, which then tag the
proteins under study. The afﬁnity of the fragments for
each other is very low and therefore ﬂuorescence comple-
mentation increases considerably when an interaction
between the respective fusion partners brings them into
close proximity. BiFC detects stable interactions: for com-
plementation to occur, the halves have to interact for
several seconds (34).
Full length wild-type Lsm11, its MPL mutant men-
tioned above, as well as CF Im25 were fused between a
Flag tag and the N-terminal 173 amino acids of the YFP
mutant Venus (Flag-Lsm11-VN, Flag-MPL-VN and
Flag-CF Im25-VN, respectively), while CF Im68 and CF
Figure 3. The interaction with CF Im68 is speciﬁc for the wild-type
N-terminus of Lsm11. (A) Analysis of the binding of hexahistidine-
tagged CF Im68 to glutathione beads containing GST-NXF1-202
(lane 2) or GST fused to the ﬁrst 157 amino acids of wild-type
mouse Lsm11 (lane 3) or of a processing-deﬁcient mutant thereof in
which the amino acids 149–151 (MPL) are replaced by three alanines
(23) (lane 4). The beads were washed, and the bound material was
analysed by western blotting (upper panel). To conﬁrm that the
absence of CF Im68 in lane 4 is not due to an absence of
GST-Nt-MPL, the blot was stained with Ponceau S (lower panel).
Input (lane 1), one-third the amount used in the binding assays was
analysed directly. (B) Analysis of the binding of hexahistidine-tagged
CF Im68 and HA-tagged CF Im25 to glutathione beads containing GST
fused to the ﬁrst 157 amino acids of wild-type Lsm11. (Lane 1) input
representing one-third the amount used in the binding assays, (lanes 2
and 3) negative controls in which equimolar amounts of His-CF Im68
(600ng) or HA-CF Im25 (200ng), repectively, were incubated with
GST. (Lanes 4–8) glutathione beads containing GST fused to the ﬁrst
157 amino acids of wild-type mouse Lsm11 that was incubated with
HA-CF Im25 (lane 4; 200ng), His-CF Im68 (lane 5; 600ng), or both
subunits with increasing amounts of HA-CF Im25 (lanes 6–8; 200, 600
1200ng). The bound material was analysed by western blotting by
using anti-His and anti-HA antibodies, respectively.
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and the C-terminal 155 Venus residues (HA-CF Im68-VC
and HA-CF Im25-VC, respectively). The use of Venus
allows for BiFC analysis under physiological conditions
and increases the signal output and speciﬁcity (25). First,
we characterized the intracellular distribution of the
fusion proteins in transiently transfected HeLa cells.
While HA-CF Im68-VC, like endogenous CF Im68, was
concentrated in the nucleus, with exclusion of the
nucleoli (21) (Figure 4A), Flag-Lsm11-VN,
Flag-MPL-VN, HA-CF Im25-VC and Flag-CF
Im25-VN, were distributed both in the cytoplasm and in
the nucleus (Figure 4B–E). In contrast, endogenous
Lsm11 was found to be similarly distributed as U7
snRNA detected by ﬂuorescent in situ hybridization (35)
and Lsm10 (5), i.e. predominantly in Cajal bodies
with some background nucleoplasmic staining
(Supplementary Figure S2). HA-CF Im25-VC was also
mostly cytoplasmic when co-expressed with
Flag-Lsm11-VN, but the presence of the green BiFC
signal (see below) prevented a double labelling of the
same cells with anti-HA and anti-Flag antibodies (data
not shown). Therefore, to analyse the distribution of
both the HA- and the Flag-tagged proteins in the same
cell, we coexpressed Flag-CF Im25-VN with HA-CF Im68,
HA-Lsm11 or HA-MPL, all of which lack the Venus
C-terminal fragment, and analysed these cells by double
immunostaining. As can be seen in Supplementary Figure
S3, HA-CF Im68 was predominatly nuclear, whereas all
three other proteins showed a mostly cytoplasmic
localization.
The observation that Flag-Lsm11-VN or the shorter
HA-Lsm11 showed a stronger cytoplasmic staining than
the endogenous protein could be explained by the fact
that, upon overexpression, some of the recombinant
protein does not get assembled into U7 snRNPs and there-
fore remains in the cytoplasm. The same could be true for
HA-CF Im25-VC or Flag-CF Im25-VN. In fact, we previ-
ously showed that nuclear localization of exogenous CF
Im25 is strongly increased by the concomitant expression
Figure 4. Interaction of CF Im68 with Lsm11 in live, unperturbed cells. (A), (B) and (C) Analysis of Lsm11/CF Im68 heterodimerization. The left
column shows immunostaining images (red) of HA-CF Im68-VC with anti-HA antibody (A) and Flag-Lsm11-VN (B) or Flag-MPL-VN (C) with
anti-Flag antibody. The right column shows BiFC (green) that occurs when the two proteins fused to the N- and C-terminal halves of Venus interact
with each other. (D) Analysis of Lsm11/CF Im25 interaction. The left column shows HA-CF Im25-VC detected with anti-HA antibody, whereas the
right column shows BiFC. (E) Analysis of CF Im68/CF Im25 heterodimerization. The left column shows Flag-CF Im25-VC detected with anti-HA
antibody (upper row) or HA-CF Im68-VC detected with anti-HA antibody (lower row), whereas the right column shows BiFC.
Nucleic Acids Research, 2010,Vol.38, No. 21 7643Figure 5. Effects of CF Im68 depletion/overexpression or CF Im25 depletion on apparent histone RNA 30-end processing in vivo.( A) Schematic
representation of quantitative (real-time) reverse transcription–PCR (qRT–PCR) assay. Total mRNA (tot) of histone H3C is measured with a
primer-probe set spanning the translation start codon. To measure the unprocessed precursors (pre), the primer-probe set spans the 30-cleavage site.
See ‘Materials and Methods’ section for further details. (B) H3C RNA 30-end processing efﬁciency in Hela cells depleted of CF Im68, CF Im25 or
Lsm11. The western blots show endogenous CF Im68 or CF Im25 detected with corresponding antibodies. SmB/B0 and b-actin served as loading
controls. The RT–PCR shows Lsm11 mRNA detected in total RNA. (C) H3C RNA 30-end processing efﬁciency in Hela cells overexpressing CF
Im68. The western blots show endogenous and HA-tagged CF Im68 detected with anti-CF Im68 antibody. SmB/B0 served as loading control. The
relative in vivo processing efﬁciency was calculated as ratio of pre-mRNA to total mRNA and then normalized with respect to the ratio obtained in
cells treated with either control siRNA, Tcrb-speciﬁc shRNA (B) or pcDNA-puro (C). The data shown represent means ± standard deviations.
Number of independent measurements (CF Im68 depletion, 5; CF Im25 depletion, 3; Lsm11 depletion, 3; CF Im68 overexpression, 4) p, signiﬁcance
values determined by Student’s t-test. (D) Northern blot detecting H3C mRNA. Nuclear RNA from control cells or cells overexpressing HA-tagged
CF Im68 was separated by polyacrylamide electrophoresis and transferred to positively charged nylon membranes. Histone H3C mRNA was
continued
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of the small subunit of CF Im requires association with
one of the larger subunits (24).
Importantly, as shown in Figure 4 (A row 2 and B row
2), a strong complementation signal was detected between
HA-CF Im68-VC and Flag-Lsm11-VN. This signal which
we observed in >90% of the cotransfected cells was pre-
dominantly nuclear with exclusion of the nucleoli and was
characterized by a patchy appearance. However, no BiFC
colocalization was observed between the MPL mutant of
Lsm11 and CF Im68 (Figure 4A row 3 and 4C row 2).
While CF Im25, CF Im68, and Lsm11 can form a
trimeric complex in vitro, in vivo there seems to be no
interaction between the small subunit of CF Im and
Lsm11 in the nucleus, where these proteins normally
reside (Figure 4D, row 2). The cytoplasmic ﬂuorescence
complementation observed between Flag-Lsm11-VN and
HA-CF Im25-VC could be an artefact of the high cyto-
plasmic level of both proteins that are not efﬁciently
imported into the nucleus. The failure of the tagged CF
Im25 to yield a nuclear BiFC signal with Lsm11 was not
due to a general deﬁciency of the CF Im25 open reading
frame, as was shown by the nuclear BiFC signal obtained
between Flag-CF Im25-VN and HA-CF Im68-VC
(Figure 4E). Control western blot analyses indicated that
the different Venus fusion proteins were expressed at
similar levels in the cells (Supplementary Figure S4).
Taken together, these experiments clearly demonstrate
that the tagged Lsm11 and CF Im68 colocalize in the cell
nucleus in a speckled pattern. In contrast, the small
subunit CF Im25 does not efﬁciently associate with
Lsm11 in the nucleus.
Altering CF Im68 levels affects apparent histone
RNA 30-end processing in vivo
Since we found CF Im68 to interact with Lsm11, but not
with the processing-defective MPL mutant, we wanted to
investigate the importance of this association for histone
pre-mRNA 30-end processing. For this purpose, we estab-
lished an assay to study a possible dependence of the
histone RNA processing reaction on CF Im68 in vivo.
The measurements are based on quantitative real-time
reverse transcription PCR (qRT–PCR) for histone H3C
total RNA and pre-RNA (‘Materials and Methods’
section). To ensure that both primer-probe sets are
speciﬁc for H3C, the one for the total mRNA spans the
AUG initiation codon (Figure 5A), thereby excluding
several non-allelic H3 genes which are very similar in the
coding sequences but differ in the 50-untranslated region.
The primer-probe set for the pre-mRNA spans the
30-processing site.
HeLa cells were depleted of CF Im68 or CF Im25 by
transfection of siRNAs. Depletion of Lsm11 by plasmids
encoding shRNAs (‘Materials and Methods’ section),
which was expected to reduce 30-end processing of
histone mRNA, was used as positive control. For all
three proteins, the depletion was almost complete within
4 days, as detected by western blot for CF Im68 and CF
Im25 or by RT–PCR for Lsm11, since in this case the
endogenous protein can not be detected by western blot
due to its very low abundance (Figure 5B). As reference
for the normalization of qRT–PCR, we used HeLa cells
similarly transfected with a control siRNA or with two
control plasmids encoding shRNAs speciﬁc for human
T-cell receptor b subunit (TcRb) mRNA that is not ex-
pressed in this cell line. Please also note that, because of
the toxicity of the Lsm11 depletion, the cells had some-
times to be harvested at different times, in order to have
enough live cells for the analysis. Moreover, in agreement
with data published by others (36), Lsm11 depletion
changed the cell cycle distribution of the cells, i.e. it
increased the G1 fraction and decreased the S and G2
fractions (Supplementary Figure S5). In contrast, neither
depletion nor overexpression of CF Im68 appeared to
induce any cell cycle changes.
In the cells transfected with control siRNAs or
shRNA-encoding plasmids, H3C pre-mRNA constituted
0.5–2% of total H3C mRNA (data not shown). As
expected, the depletion of Lsm11 affected the
30-processing of histone H3 RNA. Compared to
TcRb-depleted cells, the apparent in vivo processing efﬁ-
ciency was reduced, as reﬂected by a 3.5-fold increase in
the ratio of pre to tot RNA (Figure 5B). Most important-
ly, depletion of CF Im68 reduced the level of total histone
H3C RNA to 92%, and increased the level of histone H3
pre-mRNA to 174% in comparison to the control cells,
resulting in an overall 2-fold decrease in the apparent
in vivo processing efﬁciency (i.e. the ratio of pre to tot
RNA). In contrast, CF Im25 depletion had no signiﬁcant
effect on the apparent processing efﬁciency (Figure 5B),
although it affected b-actin and c-myc pre-mRNA pro-
cessing in a similar assay (Supplementary Figure S6).
In addition, overexpression of HA-tagged CF Im68
decreased total H3C RNA and increased H3C
pre-RNA, resulting in an overall 3.1-fold decrease in the
apparent in vivo processing activity (Figure 5C). This pro-
cessing deﬁciency was additionally reﬂected by a 2.5- and
3-fold decrease of the cytoplasmic levels of histone H3 and
histone H1 mRNAs, respectively (data not shown). A
possible explanation for this observation might be that
exogenous CF Im68 sequesters other 30-end formation
factors into non-functional complexes.
To obtain an independent read-out and to ascertain that
the changes in CF Im68 levels did not alter the transcript
structure (e.g. by favouring the use of potential down-
stream processing sites), we performed a northern blot
on nuclear RNA and probed it for histone H3C by
using a combination of two hybridization probes
(‘Materials and Methods’ section). By this approach no
alternative H3C transcripts could be detected, but HA-CF
Figure 5. Continued
detected with probes either hybridizing to the 50 or the 30-end of the mRNA. 18S rRNA served as loading control. (E) Quantitation of mRNA
levels (relative to U6 snRNA) for CF Im68 (dark columns) or CF Im25 (light columns) from cells depleted of CF Im68 or CF Im25 (number of
depletions: 3). (F) Western blot detecting endogenous CF Im68 or CF Im25 from cells transfected with a control siRNA or depleted of CF Im68 or
CF Im25. b-actin served as loading control. (G) Quantitation of CF Im68 (dark columns) and CF Im25 (light columns) protein levels, relative to
b-actin, in cells depleted of CF Im68 or CF Im25 (number of evaluated blots: 2).
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H3C (Figure 5D), in agreement with the results
obtained by qRT–PCR.
The differences between the control siRNA and CF
Im68 siRNA as well as between control or HA-CF Im68
transfected cells were highly signiﬁcant as evaluated by
Student’s t-test (Figure 5B and C). Taken together, these
experiments therefore indicate a signiﬁcant quantitative
contribution of CF Im68 to histone mRNA 30-end process-
ing in vivo.
In the course of these experiments, we made the obser-
vation that CF Im68 depletion induces a partial depletion
of CF Im25 and vice versa (Figure 5E and F).
Interestingly, this co-depletion did not only affect the
protein but also the RNA levels of the respective partner
subunit, indicating that the two CF Im subunits must
affect each other’s expression at some step of RNA
metabolism.
CF Im68 is involved in histone RNA 30-end
processing in vitro
To further clarify the role of CF Im68 in histone RNA
processing, we performed in vitro cleavage assays in the
presence of recombinant CF Im68. We titrated different
amounts of histidine-tagged CF Im68 and analysed its
effect on 30-end formation. Interestingly, the addition
of an excess of CF Im68 affected 30-end formation
(Figure 6B) leading to a >15% decrease of the processing
efﬁciency, whereas more physiological amounts slightly
stimulated 30-end formation. Although the positive effect
of the lower concentrations was very small, it was repro-
ducible. Presumably, if CF Im68 contributes to histone
RNA processing, it is not strongly limiting in the
nuclear extracts used. The stronger, but inhibitory effect
of adding an excess of 600ng of His-CF Im68 could be
seen during an entire reaction time course (Figures 6C and
D). Presumably, in this experiment, the excess CF Im68
acted by sequestering other 30end formation factors. As an
additional test for an involvement of CF Im68 in histone
RNA processing, we added  1.2mg of different antibodies
to the processing reactions. Indeed, antibodies against CF
Im68 or against the known histone RNA processing factor
CDC73/paraﬁbromin (37) inhibited the processing in
comparison to the negative control in which an antibody
against b-actin was used (Figures 6E and F).
CF Im68 is associated with both unprocessed and
processed histone pre-mRNA
Because we could demonstrate an interaction between
Lsm11 and CF Im68 in vitro as well as in vivo and
because both CF Im68 depletion and overexpression sig-
niﬁcantly inﬂuenced the 30-processing efﬁciency, we asked
if an association of CF Im68 with histone pre-mRNAs or
total RNAs can be demonstrated in vivo. Alternatively, an
interaction of CF Im68 with mature mRNAs could be
interesting in the light of a recent study of our two
groups that demonstrated a novel role of CF Im68 in
mRNA export from the nucleus to the cytoplasm (24).
To address these questions, we performed RNA
immunoprecipitations.
For this analysis, HeLa cells were ﬁxed with formalde-
hyde, and whole cell lysates, supplemented with either
anti-CF Im68 antibody or bovine serum albumin (as
negative control), were subjected to immunoprecipitation.
After washing, the formaldehyde ﬁxation was reversed by
incubation with proteinase K and heat treatment, RNA
was isolated, reverse transcribed and the amounts of
precipitated histone H3C total RNA and pre-RNA were
measured by quantitative real-time reverse transcription
PCR (qRT–PCR) as already described. The results
indicated that, in these experiments, the H3C pre-RNA
represented 0.53 ± 0.11% of the total H3C RNA. In the
immunoprecipitated sample, this proportion was
increased to 7. 8 ± 8.0%. Despite this high standard vari-
ation which resulted from a very high pre/tot ratio in one
of the immunoprecipitates, the pre/tot ratios were at least
4-fold higher in the precipitates than in the controls in all
experiments (Figure 7A). These results clearly indicate an
interaction of CF Im68 with both unprocessed histone pre-
cursors and mature histone RNA, but they also show that
the immunoprecipitation enriched the histone pre-mRNA
 10-fold, strongly suggesting that CF Im68 is present in
the 30-processing complex and that CF Im68 remains
associated with some of the processed mRNA.
Despite the fact that the in vivo depletion did not reveal
an involvement of CF Im25 in histone RNA processing
(Figure 5B), we wanted to know whether CF Im25 might
be associated with histone pre-mRNA, similar to CF Im68.
Therefore cell extracts were subjected to immunopre-
cipitation with antibodies against CF Im25 or b-actin
(negative control). The precipitated RNA was then
analysed for the presence of pre-mRNAs for histone
H3C or b-actin, or for the presence of CF Im68 mRNA
by qRT–PCR. In this experiment, H3C pre-mRNA was
not enriched in the CF Im25 immunoprecipitate compared
to the b-actin precipitate (Figure 7B). In contrast, both
b-actin pre-mRNA and CF Im68 mRNA were precipitated
signiﬁcantly more efﬁciently than by the control antibody.
Note that CF Im68 mRNA has three binding sites for CF
Im (38). Importantly, the lack of association of CF Im25
with histone pre-mRNA strongly supports the notion that
the small CF Im subunit does not participate in the
function of CF Im68 in histone RNA processing.
DISCUSSION
Our observations provide strong evidence for a new role
of CF Im68 in histone RNA 30-end processing. Although
several other components of the cleavage and
polyadenylation machinery, including all ﬁve CPSF
subunits, symplekin, as well as two CStF subunits
(CStF-64 and -77) have been found to constitute the
heat-labile histone RNA processing factor (HLF), other
components, including CF Im, have not been detected in
that complex (16), and have also not been reported to
contribute to histone RNA processing before. Here, we
have shown that CF Im68 can be found in highly
puriﬁed U7 snRNP fractions, and that it interacts with
the U7-speciﬁc Sm-like protein Lsm11. This interaction
was revealed in cell extracts by co-immunoprecipitation
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recombinant proteins (Figure 3) as well as in vivo by the
BiFC technique (Figure 4). Interestingly, this interaction
was not observed with a mutant of Lsm11 (MPL mutant)
which, when assembled with U7 snRNA, produces U7
snRNPs that are non-functional in histone RNA process-
ing (23).
These ﬁndings suggested that CF Im68 might play a role
in histone RNA 30-end processing. In line with this idea,
we found that both depletion and overexpression of CF
Im68 caused signiﬁcant decreases in the apparent in vivo
processing efﬁciency (Figure 5B and C). Although this
inibition might also have been mediated through
reduced mRNA levels for a short-lived processing factor
we consider this possibility unlikely, because depletion of
the small subunit CF Im25, which is known to affect
cleavage/polyadenylation (39) and which inhibited
apparent in vivo 30-end processing of b-actin and c-myc
mRNAs in our hands (Supplementary Figure S6), did
not affect the histone processing efﬁciency in vivo
(Figure 5B). Moreover, the reduction of apparent process-
ing measured by qRT–PCR did not appear to be due to an
Figure 6. In vitro processing. (A) Western blot detecting CF Im68 in 24ml nuclear extract and a dilution series of hexahistidine-tagged recombinant
CF Im68. (B) Graph showing the effect on the processing efﬁciency after 90min upon addition of recombinant His-CF Im68 in comparison to the
addition of the same amount of BSA. Error bars represent standard deviations for concentrations tested in multiple experiments (number of
experiments: three for 600ng, two for 30ng). (C) Autoradiography of an in vitro processing time course with the addition of 600ng BSA or
600ng His-CF Im68 to the processing reaction. (D) Graph showing the accumulation of processed substrate from the experiment shown in (C).
The time course was performed three times. One representative experiment is shown. (E) Effect of adding antibodies against CF Im68, the known
histone processing factor CDC73/paraﬁbromin, or b-actin (negative control) to processing reactions incubated for 105min. (F) Quantitation of the
results. Error bars represent standard deviations (number of experiments: three).
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processing site, as was revealed by northern blot analysis
(Figure 5D). The notion that CF Im68 participates in
histone RNA 30-end processing was further substantiated
by the ﬁnding that the addition of His-tagged CF Im68 can
stimulate or inhibit in vitro processing, dependent on the
amount added, and that the processing is speciﬁcally
inhibited by the presence of anti-CF Im68 antibody
(Figure 6). Finally, we also found that histone mRNA
precursors are enriched  14-fold by immunoprecipitation
of CF Im68 (Figure 7A).
Interestingly, while the small CF Im, subunit, CF Im25,
can form trimeric complexes with CF Im68 and Lsm11
in vitro (Figure 2) and can associate with Lsm11 in the
cytoplasm when both proteins are overexpressed in the
same cell (Figure 4D), it does not appear to interact
with Lsm11 in vivo (Supplementary Figure S2). Its deple-
tion also does not affect histone RNA 30-end processing,
as already mentioned above (Figure 5B), and it is not
found associated with histone pre-mRNA (Figure 7B).
All these results strongly suggest that CF Im68 may exist
in two different states: one, associated with CF Im25, that
is involved in cleavage/polyadenylation and the other, free
of CF Im25, which participates in histone mRNA metab-
olism. How these two states of CF Im68 are controlled will
be an interesting topic for future investigations.
In this context, it is noteworthy that we found the two
subunits of CF Im to be co-regulated (Figure 6E–G). The
depletion of CF Im68 led to a reduction of CF Im25
mRNA and protein levels and vice versa, but not to a
complete depletion. The fact that, in both cases, the re-
duction in mRNA level of the co-regulated gene was com-
mensurate with that of the protein indicates that the two
proteins affect each other’s expression at some step of
RNA metabolism. Although we presently have no experi-
mental data, the most likely steps to be affected are
cleavage/polyadenylation, mRNA export or mRNA sta-
bility. Such a mutual cross-regulation makes sense for two
proteins which depend on each other for most of their
functions. In particular, it may be important for the cell
not to allow CF Im25, which carries the main RNA
binding activity of CF Im, to accumulate to high levels
or to enter the nucleus. Its accumulation can be prevented
by the cross-regulation mechanism discovered here,
whereas the previous discovery that CF Im25 requires
one of the larger CF Im subunits to efﬁciently enter the
nucleus (24) would ensure that free CF Im25 does not
massively enter the nucleus with possible negative conse-
quences for the expression of many genes. It will be inter-
esting to analyse how this co-regulation works at the
molecular level and to see whether other multi-subunit
30-end formation factors are subjected to a similar
regulation.
Although a histone 30-processing signal by itself may be
efﬁciently recognized in an in vitro processing system, it is
not certain whether the same signal is sufﬁciently well
deﬁned to achieve efﬁcient cleavage in vivo. Aided by a
local concentration within histone processing bodies
(40), HBP and the U7 snRNP, with the help of ZFP100,
may bind efﬁciently to nascent histone pre-mRNAs.
However, the interaction of these cleavage site recognition
components with HLF has not been characterized and
may require additional helpers in vivo. Along these lines,
it is interesting that an RNA element in the coding
sequence of histone genes was shown to act as a binding
site for U2 snRNPs and that this binding could stimulate
U7-dependent RNA 30-cleavage (17). It has not yet been
clariﬁed how this stimulation works, but, based on a study
on 30-terminal exon deﬁnition in polyadenylation sub-
strates (18), the mechanism may involve an interaction
between the U2 snRNP and CPSF. Additionally to the
U2 snRNP, also SR proteins such as SRp20 and 9G8
can bind to the sequence element in the coding region of
histone mRNAs, and this interaction was found to stimu-
late histone mRNA export (41). Since CF Im68 is known
to bind to these SR proteins via its C-terminal alternating
charge domain (21), it is also possible that it links the U7
snRNP to this mRNA internal element. Alternatively or
additionally, CF Im68 might contribute to histone process-
ing by helping the U7 snRNP to attract the cleavage
effector HLF to the cleavage site that has already been
Figure 7. (A) Co-immunoprecipitation of histone H3C pre-mRNA and
total RNA with CF Im68. The graph shows the ratio between
pre-mRNA and total histone H3C RNAs either in the input sample
(light columns) or after co-immunprecipitation with anti-CF Im68 (dark
columns) as determined in three independent experiments. In
Experiments 1 and 3 no RNA contamination was detected in the
negative controls (BSA-coated beads), whereas for Experiment 2 the
contamination is shown as grey column. (B) Co-immunoprecipitation
of histone H3C pre-mRNA (light columns), b-actin pre-mRNA (dark
columns) and CF Im68 mRNA with CF Im25. An antibody against
b-actin served as negative control. The cells were ﬁxed with formalde-
hyde prior to total cell extract preparation and immunprecipitation. All
precipitated transcripts were quantitated by qRT–PCR (number of ex-
periments: two).
7648 Nucleic Acids Research, 2010,Vol.38, No. 21deﬁned by the U7 snRNP, HBP and ZFP100. Together
with the supporting function of the U2 snRNP, this could
result in an enhancement of 30-end cleavage not unlike the
one seen in 30-terminal exon deﬁnition. To underline these
parallels between polyadenylation substrates and
metazoan histone pre-mRNAs, one should perhaps refer
to them as ‘30-cleavage exons’.
An interaction between CF Im68 and SR proteins
bound to the mRNA internal element could also have
implications for the nucleo-cytoplasmic transport of
histone mRNA. Our observation that not only histone
pre-mRNAs, but also a fraction of mature mRNAs, are
immunoprecipitated along with CF Im68 (Figure 7A) in-
dicates that an interaction exists at least for a
subpopulation of cleaved histone mRNAs. Important in
this respect, we have recently described a function of CF
Im68 in promoting the export of polyadenylated mRNAs
from the nucleus (24). A similar role for the export of
histone mRNAs therefore appears possible, but it could
not be tested with the experiments described here, because
of the effect that CF Im68 has on in vivo processing.
Further experiments more speciﬁcally measuring
nucleo-cytoplasmic transport will be required to explore
this possibility.
In conclusion, our data indicate that CF Im68 plays one
or more important role(s) in the expression of histone
mRNAs. It increases the efﬁciency of 30-end processing
in vivo, presumably by helping to attract HLF to the
factors directly recognizing the processing substrate and
thereby improving the deﬁnition of the ‘30-cleavage exon’.
Moreover, it may also stimulate histone mRNA export.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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